Neprilysin inhibitors
US-9499487-B2 · Nov 22, 2016 · US
US9783507B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9783507-B2 |
| Application number | US-201715419217-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 30, 2017 |
| Priority date | Jan 30, 2014 |
| Publication date | Oct 10, 2017 |
| Grant date | Oct 10, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In one aspect, the invention relates to compounds having the formula I: where R 1 -R 6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising these compounds; methods of using these compounds; and processes and intermediates for preparing these compounds.
Opening claim text (preview).
What is claimed is: 1. A compound of Formula 1: where: R 1 is H, —C 1-8 alkyl, —CH(CH 3 )OC(O)—O-cyclohexyl, —(CH 2 ) 2 -morpholinyl, or —CH 2 - 5-methyl-[1,3]dioxol-2-one; R 2 is —C 0-3 alkylene-NR 22 R 23 ; R 22 is H or —C 1-6 alkyl; R 23 is H, —C 1-6 alkyl, —C 1-6 alkyl substituted with 1 to 6 fluoro atoms, —SO 2 —C 1-6 alkyl, —CH 2 OC(O)—C 1-6 alkyl, —C 2-4 alkylene-OH, —C 2-4 alkylene-O—CH 3 , or cyclopropyl optionally substituted with one or two R 31 groups; or R 22 and R 23 are taken together to form —(CH 2 ) 2 —O—(CH 2 ) 2 —, a 2-oxa-6-aza-spiro[3.3]heptane ring, or an azetidine ring optionally substituted with one or two R 31 groups; and each R 31 is independently halo, —C 1-6 alkyl, —C 0-2 alkylene-OH, —C 0-2 alkylene-OC 1-6 alkyl, —CN, or —CONH 2 ; R 3 , R 4 and R 5 are independently H or halo; and P 1 is H or an amino-protecting group selected from the group consisting of t-butoxycarbonyl, trityl, benzyloxycarbonyl, 9-fluorenylmethoxycarbonyl, formyl, trimethylsilyl, and t-butyldimethylsilyl; or a salt thereof.
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title
attached in position 2 · CPC title
Amides; Imides · CPC title
One oxygen atom attached in position 3 or 5 · CPC title
1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.